David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.1% |
| 2 | Technology | 16.45% |
| 3 | Consumer Discretionary | 10.49% |
| 4 | Communication Services | 9.04% |
| 5 | Healthcare | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Black Hills Corp
BKH
$5.59B
| $2.75M | ﹤0.01% |
41,266
-177,986
| -81% | -$11.1M |
|
2177
CALL
Ultragenyx Pharmaceutical
RARE
$2.56B
| $2.75M | ﹤0.01% |
24,200
| – | – |
|
|
SJR
2178
DELISTED
Shaw Communications Inc.
SJR
| $2.75M | ﹤0.01% |
105,849
-318,090
| -75% | -$6.28M |
|
|
KNL
2179
DELISTED
Knoll, Inc.
KNL
| $2.75M | ﹤0.01% |
166,664
-52,939
| -24% | -$866K |
|
2180
CALL
GDS Holdings
GDS
$6.67B
| $2.75M | ﹤0.01% |
33,900
+23,900
| +239% | +$2.38M |
|
2181
CALL
Phillips 66
PSX
$96.7B
| $2.75M | ﹤0.01% |
33,700
-40,700
| -55% | -$3.19M |
|
2182
Jazz Pharmaceuticals
JAZZ
$16.3B
| $2.74M | ﹤0.01% |
16,694
+3,909
| +31% | +$643K |
|
|
TDAY
2183
USA Today Co
TDAY
$944M
| $2.74M | ﹤0.01% |
509,877
-74,341
| -13% | -$364K |
|
|
VLTA
2184
DELISTED
Volta Inc.
VLTA
| $2.74M | ﹤0.01% |
+250,000
| New | +$3.08M |
|
|
ACQRU
2185
DELISTED
Independence Holdings Corp. Units
ACQRU
| $2.74M | ﹤0.01% |
+273,786
| New | +$2.76M |
|
|
RWT
2186
Redwood Trust
RWT
$582M
| $2.74M | ﹤0.01% |
262,853
-501,902
| -66% | -$4.82M |
|
|
SWI
2187
DELISTED
SolarWinds Corporation Common Stock
SWI
| $2.73M | ﹤0.01% |
148,378
+127,540
| +612% | +$2.2M |
|
2188
Wheaton Precious Metals
WPM
$71.8B
| $2.72M | ﹤0.01% |
71,266
-38,794
| -35% | -$1.54M |
|
|
SLCA
2189
CALL
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $2.72M | ﹤0.01% |
+221,400
| New | +$2.41M |
|
2190
FS KKR Capital
FSK
$3.35B
| $2.72M | ﹤0.01% |
+137,187
| New | +$2.55M |
|
2191
KE Holdings
BEKE
$19.6B
| $2.71M | ﹤0.01% |
+47,597
| New | +$2.99M |
|
|
VRAY
2192
DELISTED
ViewRay, Inc.
VRAY
| $2.71M | ﹤0.01% |
623,459
+124,218
| +25% | +$603K |
|
|
GLUU
2193
DELISTED
Glu Mobile Inc.
GLUU
| $2.71M | ﹤0.01% |
216,872
-389,235
| -64% | -$4.34M |
|
|
PRFT
2194
DELISTED
Perficient Inc
PRFT
| $2.7M | ﹤0.01% |
+46,020
| New | +$2.6M |
|
2195
PUT
SAP
SAP
$255B
| $2.7M | ﹤0.01% |
22,000
| – | – |
|
|
LEGAU
2196
DELISTED
Lead Edge Growth Opportunities, Ltd Units
LEGAU
| $2.7M | ﹤0.01% |
+270,911
| New | +$2.7M |
|
2197
Azenta
AZTA
$1.47B
| $2.7M | ﹤0.01% |
+33,068
| New | +$2.67M |
|
2198
Pathward Financial
CASH
$1.69B
| $2.7M | ﹤0.01% |
+59,565
| New | +$2.54M |
|
|
CLDT
2199
Chatham Lodging
CLDT
$623M
| $2.7M | ﹤0.01% |
205,085
+89,213
| +77% | +$1.13M |
|
|
CCMP
2200
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $2.7M | ﹤0.01% |
+15,247
| New | +$2.53M |
|
Similar funds
David Shaw's Q1 2021 Portfolio in Review
As of Q1 2021, David Shaw held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
David Shaw withdrew a net $10.4B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 35% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Baidu worth $627M.
- David Shaw's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- David Shaw added most to Tesla in Q1 2021, an estimated $862M increase.
- David Shaw's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- David Shaw fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- David Shaw's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- David Shaw opened 825 new positions and closed 730 in Q1 2021.
- David Shaw's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.